Market Cap 462.82M
Revenue (ttm) 240,000.00
Net Income (ttm) -64.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -26,675.00%
Debt to Equity Ratio 0.00
Volume 2,010,000
Avg Vol 1,704,042
Day's Range N/A - N/A
Shares Out 89.00M
Stochastic %K 45%
Beta 0.88
Analysts Strong Sell
Price Target $18.83

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitiv...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 731 8389
Fax: 858 731 8394
Address:
10240 Sorrento Valley Road, Suite 300, San Diego, United States
joshua_slone
joshua_slone Jun. 16 at 8:00 PM
$ATYR Does anyone know why ATYR pivoted from Resolaris back in 2017-2018? Seems those trials were going good but they discontinued it
0 · Reply
StolenGoods
StolenGoods Jun. 16 at 7:59 PM
0 · Reply
BioBingo
BioBingo Jun. 16 at 1:41 PM
$ATYR – What’s On This Week: Options Expiry, Tight Float, and Market Positioning $ATYR is entering a crucial week with June 20 options expiry in focus, float tighter than ever (~70% institutional), and retail interest hitting all-time highs (see Google Trends). After a massive run from $3.50 to $6.00 and healthy consolidation above $5.00, the setup is defined by high gamma exposure, short interest (15.8% of float), and sky-high implied volatility (IV30 >100%). With no major news on the calendar, market structure is driving the action—sharp moves in either direction possible as positioning shifts. Watch for options flow, borrow rates, and institutional behavior. This “pause” may be more pivotal than it looks. Read the deep dive: https://www.reddit.com/r/ATYR_Alpha/s/6J3JPaXRCl
1 · Reply
bassman4444
bassman4444 Jun. 15 at 5:15 PM
$ATYR $NAK Charlie Munger Says, "The Big Money Is Not In The Buying And The Selling But In The Waiting"
0 · Reply
PennyMagician
PennyMagician Jun. 14 at 3:32 AM
$ATYR tbh, I'll take any chance to buy this lower. Can't miss the train, though. Gonna have to find a homeostasis.
2 · Reply
RJLeonii
RJLeonii Jun. 13 at 11:20 PM
$ATYR always buy when the shorts get too cocky. See how ridiculous that strategy sounds? Excellent research data ✅. Strong management ✅. Phase III underway ✅. Multiple analyst upgrades ✅.
0 · Reply
bucko1212
bucko1212 Jun. 13 at 8:32 PM
$ATYR AHHH They just launched missiles in the Middle East, I better sell this bio stock whose potential profitability is tied exclusively to phase 3 disease study data that has nothing to do with the Middle East.
2 · Reply
Hereinbama35
Hereinbama35 Jun. 13 at 6:55 PM
$ATYR I’m buying the dip. Been here before.
0 · Reply
JDW561
JDW561 Jun. 13 at 6:52 PM
$ATYR low float stocks hate war? XBI in the shitter. Log off come back next week.
0 · Reply
creditgoo
creditgoo Jun. 13 at 6:41 PM
$ATYR easist short of the month for me
1 · Reply
Latest News on ATYR
aTyr Pharma to Present at Upcoming Investor Conferences

May 20, 2025, 8:00 AM EDT - 27 days ago

aTyr Pharma to Present at Upcoming Investor Conferences


aTyr Pharma to Participate in April Investor Conferences

Apr 3, 2025, 8:00 AM EDT - 2 months ago

aTyr Pharma to Participate in April Investor Conferences


aTyr Pharma, Inc. (ATYR) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 11:18 PM EDT - 3 months ago

aTyr Pharma, Inc. (ATYR) Q4 2024 Earnings Call Transcript


aTyr Pharma: The Bull Has Finally Come Out

Oct 24, 2024, 1:00 PM EDT - 8 months ago

aTyr Pharma: The Bull Has Finally Come Out


aTyr Pharma to Participate in September Investor Conferences

Aug 21, 2024, 8:00 AM EDT - 10 months ago

aTyr Pharma to Participate in September Investor Conferences


aTyr Pharma, Inc. (LIFE) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 11:37 PM EDT - 1 year ago

aTyr Pharma, Inc. (LIFE) Q4 2023 Earnings Call Transcript


aTyr Pharma to Present at November Investor Conferences

Nov 1, 2023, 8:00 AM EDT - 1 year ago

aTyr Pharma to Present at November Investor Conferences


aTyr Pharma, Inc. (LIFE) Q4 2022 Earnings Call Transcript

Mar 10, 2023, 5:12 PM EST - 2 years ago

aTyr Pharma, Inc. (LIFE) Q4 2022 Earnings Call Transcript


aTyr Pharma to Present at March Investor Conferences

Mar 8, 2023, 8:00 AM EST - 2 years ago

aTyr Pharma to Present at March Investor Conferences


joshua_slone
joshua_slone Jun. 16 at 8:00 PM
$ATYR Does anyone know why ATYR pivoted from Resolaris back in 2017-2018? Seems those trials were going good but they discontinued it
0 · Reply
StolenGoods
StolenGoods Jun. 16 at 7:59 PM
0 · Reply
BioBingo
BioBingo Jun. 16 at 1:41 PM
$ATYR – What’s On This Week: Options Expiry, Tight Float, and Market Positioning $ATYR is entering a crucial week with June 20 options expiry in focus, float tighter than ever (~70% institutional), and retail interest hitting all-time highs (see Google Trends). After a massive run from $3.50 to $6.00 and healthy consolidation above $5.00, the setup is defined by high gamma exposure, short interest (15.8% of float), and sky-high implied volatility (IV30 >100%). With no major news on the calendar, market structure is driving the action—sharp moves in either direction possible as positioning shifts. Watch for options flow, borrow rates, and institutional behavior. This “pause” may be more pivotal than it looks. Read the deep dive: https://www.reddit.com/r/ATYR_Alpha/s/6J3JPaXRCl
1 · Reply
bassman4444
bassman4444 Jun. 15 at 5:15 PM
$ATYR $NAK Charlie Munger Says, "The Big Money Is Not In The Buying And The Selling But In The Waiting"
0 · Reply
PennyMagician
PennyMagician Jun. 14 at 3:32 AM
$ATYR tbh, I'll take any chance to buy this lower. Can't miss the train, though. Gonna have to find a homeostasis.
2 · Reply
RJLeonii
RJLeonii Jun. 13 at 11:20 PM
$ATYR always buy when the shorts get too cocky. See how ridiculous that strategy sounds? Excellent research data ✅. Strong management ✅. Phase III underway ✅. Multiple analyst upgrades ✅.
0 · Reply
bucko1212
bucko1212 Jun. 13 at 8:32 PM
$ATYR AHHH They just launched missiles in the Middle East, I better sell this bio stock whose potential profitability is tied exclusively to phase 3 disease study data that has nothing to do with the Middle East.
2 · Reply
Hereinbama35
Hereinbama35 Jun. 13 at 6:55 PM
$ATYR I’m buying the dip. Been here before.
0 · Reply
JDW561
JDW561 Jun. 13 at 6:52 PM
$ATYR low float stocks hate war? XBI in the shitter. Log off come back next week.
0 · Reply
creditgoo
creditgoo Jun. 13 at 6:41 PM
$ATYR easist short of the month for me
1 · Reply
creditgoo
creditgoo Jun. 13 at 6:12 PM
$ATYR already up 10%
2 · Reply
Killamlc
Killamlc Jun. 13 at 5:12 PM
$ATYR head and shoulders probably done for the day here
2 · Reply
Hereinbama35
Hereinbama35 Jun. 13 at 2:10 PM
$ATYR You might be shorting it all the way to $15 a share.
0 · Reply
creditgoo
creditgoo Jun. 13 at 1:57 PM
$ATYR short lookong good. Always short when the big boys post their gains
0 · Reply
BioBingo
BioBingo Jun. 13 at 1:04 PM
$ATYR – Forget the Panic: A Real-World Guide to Risk Management in Volatile Times In the wake of the latest geopolitical shocks, it’s easy to get caught up in noise and emotion—especially for biotech investors. But in my view, this is the moment to lean into process, not panic. I’ve put together a detailed, step-by-step risk management guide built for exactly this environment, using $ATYR as the case study. It covers how to break down risk, identify what really matters, and turn volatility into an opportunity to refine your approach—rather than just react. Whether you’re holding through uncertainty or thinking about your next move, this framework will help you separate signal from noise. Full deep-dive here: https://www.reddit.com/r/ATYR_Alpha/s/3hWSt9lM9w
0 · Reply
CrispDry
CrispDry Jun. 13 at 12:11 PM
$ATYR they don’t have any commercialized products right?
3 · Reply
Selfmademan
Selfmademan Jun. 13 at 11:47 AM
$ATYR will be my last tango in stock markets and i just know the dance will be epic and give me amazing exit. I can 100% relate to Sanjay when he says the shore is within reach. Just few more miles.
1 · Reply
BioBingo
BioBingo Jun. 12 at 7:06 PM
$ATYR – Inside the Quiet: Mapping the Market Between Data and Readout We’re in the part of the $ATYR cycle where nothing looks like it’s happening—but everything is quietly resetting. Float’s tightening, IV is reloading, and institutional behaviour matters more than headlines. This isn’t just about sarcoidosis data—it’s about how markets position during biotech lulls. I’ve written a long-form piece walking through structure, sentiment, options, and what might happen next. If you follow $ATYR or trade biotech setups, it’s worth a read. 📎 Full breakdown here: https://www.reddit.com/r/ATYR_Alpha/s/Cm9IJjk2le
1 · Reply
Hereinbama35
Hereinbama35 Jun. 12 at 4:36 PM
$ATYR My cost basis is under $4, maybe I can afford to average up a little. 😀
2 · Reply
AutoFillGeri
AutoFillGeri Jun. 12 at 3:10 PM
$ATYR adding 🫵💪
0 · Reply
Mt385
Mt385 Jun. 12 at 2:29 PM
$ATYR anyone know anything about atyr 1940 , the muscular dystrophy application in trial right now?
2 · Reply